November 25, 2025 Experience Illumina $500 million notes offering We advised the underwriters on the offering
November 25, 2025 Experience Equinix C$700 million debut Canadian dollar notes offering We advised Equinix on the investment-grade offering
November 18, 2025 Experience Ionis Pharmaceuticals $770 million convertible senior notes offering We advised the representatives of the initial purchasers on the offering
November 14, 2025 Experience Equinix $1.25 billion notes offering We advised Equinix on the investment-grade offering
November 7, 2025 Experience Alphabet €6.5 billion notes offering The investment-grade notes were issued in six tranches
November 7, 2025 Experience Alphabet $17.5 billion notes offering The investment-grade notes were issued in eight tranches
November 6, 2025 Experience Ardelyx $100 million at-the-market offering The shares are listed on the Nasdaq Global Market
October 24, 2025 Experience RAPT Therapeutics $250 million follow-on offering The shares are listed on the Nasdaq Global Market
October 24, 2025 Experience Nurix Therapeutics $250 million stock offering The stock is listed on the Nasdaq Global Market
October 7, 2025 Experience Credo Technology $750 million at-the-market offering We advised Credo on the offering